+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bisacodyl Market by Administration Type, Application, Distribution Channels - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967615
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bisacodyl Market grew from USD 1.28 billion in 2023 to USD 1.35 billion in 2024. It is expected to continue growing at a CAGR of 6.49%, reaching USD 1.99 billion by 2030.

Bisacodyl, a stimulant laxative, is primarily used to promote bowel movements and treat constipation. The scope of bisacodyl encompasses pharmaceutical applications and administering bowel preparation prior to medical examinations such as colonoscopies. Its necessity arises from increasing incidences of lifestyle-induced gastrointestinal issues and higher prevalence of conditions like irritable bowel syndrome (IBS). Bisacodyl is commonly available in oral tablet and rectal suppository forms, providing versatility in application. The end-use scope involves hospitals, clinics, and households, given its over-the-counter availability.

Market insights indicate steady growth driven by the rise in digestive health awareness and a growing elderly population prone to constipation. The expansion of healthcare infrastructure in developing regions contributes significantly to market growth. However, market expansion faces limitations due to potential side effects like cramping and diarrhea, causing hesitation in adoption. Regulatory challenges and competition from alternative treatments further impact growth. Despite these challenges, the ongoing shift towards self-medication and increased access to healthcare information bolster market dynamics.

Key opportunities include the development of bisacodyl formulations with minimized side effects, tapping into the natural product trend, and integrating digital health technologies for personalized medicine. Companies can innovate by formulating bisacodyl with extended-release profiles or combining it with complementary herbal compounds. Research into patient-specific formulations could cater to sensitive demographics, like pediatrics and geriatrics, offering personalized dosages and delivery methods. Additionally, expanding presence in emerging markets by leveraging localized marketing strategies and education campaigns can provide a competitive edge.

The nature of the bisacodyl market is competitive, with major players investing in R&D and product differentiation. To sustain growth, businesses must navigate regulatory landscapes efficiently and collaborate with healthcare professionals for better consumer education and confidence. Addressing these challenges with innovative, patient-centered solutions holds the potential for substantial market impact.

Understanding Market Dynamics in the Bisacodyl Market

The Bisacodyl Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of constipation and neurogenic bowel dysfunction
    • Increasing adoption of over-the-counter bisacodyl drug
  • Market Restraints
    • Volatile prices of raw materials used in manufacturing of bisacodyl
  • Market Opportunities
    • Ongoing research & developments for innovative drug formulation and delivery methods
    • Technological advancements in manufacturing methods
  • Market Challenges
    • Availability of alternative to bisacodyl

Exploring Porter’s Five Forces for the Bisacodyl Market

Porter’s Five Forces framework further strengthens the insights of the Bisacodyl Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Bisacodyl Market

External macro-environmental factors deeply influence the performance of the Bisacodyl Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Bisacodyl Market

The Bisacodyl Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Bisacodyl Market

The Bisacodyl Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Bisacodyl Market

The Bisacodyl Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bisacodyl Market, highlighting leading vendors and their innovative profiles. These include Cambrex Corporation, Carbogen AMCIS, Centurion Remedies Private Limited, Cipla Limited, Dr. Reddy's Laboratories, Enomark, Erregierre Spa, GlaxoSmithKline plc, Joshi Agrochem Pharma, Kreative Organics Private Limited, Lexicare Pharma Pvt. Ltd., LMG Pharma, Mahendra Chemicals, Manus Aktteva Biopharma LLP, Merck KGaA, Sanofi S.A., Tiefenbacher API + Ingredients GmbH & Co. KG, and Zuche Pharmaceuticals Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Bisacodyl Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Administration Type
    • Oral Medications
    • Suppository Medications
  • Application
    • Constipation
    • Neurogenic Bowl Dysfunction
  • Distribution Channels
    • Hospital Pharmacy
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of constipation and neurogenic bowel dysfunction
5.1.1.2. Increasing adoption of over-the-counter bisacodyl drug
5.1.2. Restraints
5.1.2.1. Volatile prices of raw materials used in manufacturing of bisacodyl
5.1.3. Opportunities
5.1.3.1. Ongoing research & developments for innovative drug formulation and delivery methods
5.1.3.2. Technological advancements in manufacturing methods
5.1.4. Challenges
5.1.4.1. Availability of alternative to bisacodyl
5.2. Market Segmentation Analysis
5.2.1. Administration Type: Significant adoption of over-the-counter (OTC) oral bisacodyl
5.2.2. Application: Increasing utilization of bisacodyl in managing constipation and neurogenic bowel dysfunction
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Bisacodyl Market, by Administration Type
6.1. Introduction
6.2. Oral Medications
6.3. Suppository Medications
7. Bisacodyl Market, by Application
7.1. Introduction
7.2. Constipation
7.3. Neurogenic Bowl Dysfunction
8. Bisacodyl Market, by Distribution Channels
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Americas Bisacodyl Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Bisacodyl Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Bisacodyl Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. BISACODYL MARKET RESEARCH PROCESS
FIGURE 2. BISACODYL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BISACODYL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. BISACODYL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. BISACODYL MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BISACODYL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BISACODYL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BISACODYL MARKET DYNAMICS
TABLE 7. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BISACODYL MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BISACODYL MARKET SIZE, BY SUPPOSITORY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BISACODYL MARKET SIZE, BY CONSTIPATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BISACODYL MARKET SIZE, BY NEUROGENIC BOWL DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BISACODYL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BISACODYL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BISACODYL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 27. CANADA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 30. MEXICO BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 44. CHINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 47. INDIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 53. JAPAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 71. THAILAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 84. EGYPT BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 87. FINLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 90. FRANCE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 93. GERMANY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 99. ITALY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 108. NORWAY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 111. POLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 114. QATAR BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 126. SPAIN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 135. TURKEY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 144. BISACODYL MARKET SHARE, BY KEY PLAYER, 2023
TABLE 145. BISACODYL MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Bisacodyl Market, which are profiled in this report, include:
  • Cambrex Corporation
  • Carbogen AMCIS
  • Centurion Remedies Private Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • Enomark
  • Erregierre Spa
  • GlaxoSmithKline plc
  • Joshi Agrochem Pharma
  • Kreative Organics Private Limited
  • Lexicare Pharma Pvt. Ltd.
  • LMG Pharma
  • Mahendra Chemicals
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • Sanofi S.A.
  • Tiefenbacher API + Ingredients GmbH & Co. KG
  • Zuche Pharmaceuticals Pvt. Ltd.

Methodology

Loading
LOADING...

Table Information